As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Irish Examiner on MSN2d
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predictMedical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Antibiotic use was not associated with an increased risk of cognitive impairment and dementia in healthy older adults, ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...
All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback